{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:46:55Z","timestamp":1782280015263,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Johns Hopkins University School of Medicine"},{"DOI":"10.13039\/100014804","name":"Neurofibromatosis Therapeutic Acceleration Program","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014804","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jpeds.2018.10.019","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T06:58:05Z","timestamp":1541487485000},"page":"190-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Patient Reported Outcomes Measurement Information System and Quality of Life in Neurological Disorders Measurement System to Evaluate Quality of Life for Children and Adolescents with Neurofibromatosis Type 1 Associated Plexiform Neurofibroma"],"prefix":"10.1016","volume":"206","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1840-2537","authenticated-orcid":false,"given":"Jin-Shei","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally E.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Charrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Listernick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2018.10.019_bib0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152a","author":"Evans","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W","article-title":"Plexiform neurofibromas","volume":"89","author":"Korf","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1215\/15228517-2008-011","article-title":"Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1","volume":"10","author":"Mautner","year":"2008","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11060-015-1725-1","article-title":"Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literature","volume":"122","author":"Vranceanu","year":"2015","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0030","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1212\/01.wnl.0000250332.89420.e6","article-title":"NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight","volume":"68","author":"Dombi","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ajmg.a.37987","article-title":"Using a qualitative approach to conceptualize concerns of patients with neurofibromatosis type 1 associated plexiform neurofibromas (pNF) across the lifespan","volume":"173","author":"Lai","year":"2016","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0040","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archderm.137.11.1421","article-title":"Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases","volume":"137","author":"Wolkenstein","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0045","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/ajmg.a.31422","article-title":"Impact of neurofibromatosis 1 on quality of life: a cross-sectional study of 176 American cases","volume":"140A","author":"Page","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0050","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas","volume":"375","author":"Dombi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11060-017-2723-2","article-title":"PedsQL Neurofibromatosis Type 1 module for children, adolescents and young adults: feasibility, reliability, and validity","volume":"137","author":"Nutakki","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0060","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","article-title":"The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008","volume":"63","author":"Cella","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11136-011-9958-8","article-title":"Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing","volume":"21","author":"Gershon","year":"2012","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0070","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s11136-010-9619-3","article-title":"An item response analysis of the pediatric PROMIS anxiety and depressive symptoms scales","volume":"19","author":"Irwin","year":"2010","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0075","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/jpepsy\/jsy010","article-title":"Psychometric evaluation of the PROMIS\u00ae pediatric psychological and physical stress experiences measures","volume":"43","author":"Bevans","year":"2018","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0080","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s11136-013-0357-1","article-title":"Development and psychometric properties of the PROMIS\u00ae pediatric fatigue item banks","volume":"22","author":"Lai","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0085","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jpain.2010.02.005","article-title":"PROMIS pediatric pain interference scale: an item response theory analysis of the pediatric pain item bank","volume":"11","author":"Varni","year":"2010","journal-title":"J Pain"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11136-017-1681-7","article-title":"Development and psychometric evaluation of the PROMIS Pediatric Life Satisfaction item banks, child-report, and parent-proxy editions","volume":"27","author":"Forrest","year":"2017","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0095","first-page":"1","article-title":"Development and evaluation of the PROMIS\u00ae pediatric positive affect item bank, child-report and parent-proxy editions","author":"Forrest","year":"2017","journal-title":"J Happiness Stud"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0100","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jclinepi.2010.10.012","article-title":"Construction of the eight-item Patient-Reported Outcomes Measurement Information System pediatric physical function scales: built using item response theory","volume":"64","author":"DeWitt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jpainsymman.2017.05.008","article-title":"Computerized adaptive testing in pediatric brain tumor clinics","volume":"54","author":"Lai","year":"2017","journal-title":"J Pain Symptom Manage"},{"issue":"Suppl 1","key":"10.1016\/j.jpeds.2018.10.019_bib0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11136-007-9204-6","article-title":"The future of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessment","volume":"16","author":"Cella","year":"2007","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/1545968311412054","article-title":"Quality-of-life measures in children with neurological conditions: pediatric Neuro-QOL","volume":"26","author":"Lai","year":"2012","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0120","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11136-015-1111-7","article-title":"Concurrent validity of the PROMIS\u00ae pediatric global health measure","volume":"25","author":"Forrest","year":"2015","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0125","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/jpepsy\/jsr005","article-title":"Development of a parent-report cognitive function item bank using item response theory and exploration of its clinical utility in computerized adaptive testing","volume":"36","author":"Lai","year":"2011","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0130","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.apmr.2010.08.033","article-title":"How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS Fatigue item bank example","volume":"92","author":"Lai","year":"2011","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1073191111411667","article-title":"Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS):depression, anxiety, and anger","volume":"18","author":"Pilkonis","year":"2011","journal-title":"Assessment"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2214.2006.00717.x","article-title":"The self-concept of children and adolescents with neurofibromatosis type 1","volume":"33","author":"Barton","year":"2007","journal-title":"Child Care Health Dev"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0145","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1017\/S0012162204000921","article-title":"Social skills of children with neurofibromatosis type 1","volume":"46","author":"Barton","year":"2004","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0150","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/ajmg.a.31923","article-title":"Social, emotional, and behavioral functioning of children with NF1","volume":"143","author":"Noll","year":"2007","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0155","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/0883073817749367","article-title":"Psychosocial features of neurofibromatosis type 1 in children and adolescents","volume":"33","author":"Domon-Archambault","year":"2018","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2008.08.045","article-title":"Health-related quality of life in children with neurofibromatosis type 1: contribution of demographic factors, disease-related factors, and behavior","volume":"154","author":"Krab","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11060-013-1195-2","article-title":"Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature","volume":"114","author":"Vranceanu","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0170","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e3181bd1326","article-title":"Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas","volume":"73","author":"Kim","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0175","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jpeds.2011.04.008","article-title":"Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits","volume":"159","author":"Nguyen","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0180","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/ajmg.a.37123","article-title":"Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life","volume":"167a","author":"Wolters","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0185","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jpeds.2007.03.005","article-title":"Parental reports of health-related quality of life in young children with neurofibromatosis type 1: influence of condition specific determinants","volume":"151","author":"Oostenbrink","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0190","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1469-8749.2012.04399.x","article-title":"Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence","volume":"55","author":"Lehtonen","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0195","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1469-8749.2010.03639.x","article-title":"Social information processing in children and adolescents with neurofibromatosis type 1","volume":"52","author":"Huijbregts","year":"2010","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0200","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0205","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s11136-013-0548-9","article-title":"Parent-reported cognition of children with cancer and its potential clinical usefulness","volume":"23","author":"Lai","year":"2014","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0210","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2288-11-72","article-title":"Concordance of self-reported and medical chart information on cancer diagnosis and treatment","volume":"11","author":"Gupta","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jpeds.2018.10.019_bib0215","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ajem.2013.06.014","article-title":"Discordance between patient report and chart review of risk factors for antimicrobial resistance in ED patients","volume":"31","author":"Caterino","year":"2013","journal-title":"Am J Emerg Med"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347618314318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347618314318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T10:34:02Z","timestamp":1589970842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347618314318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":42,"alternative-id":["S0022347618314318"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2018.10.019","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient Reported Outcomes Measurement Information System and Quality of Life in Neurological Disorders Measurement System to Evaluate Quality of Life for Children and Adolescents with Neurofibromatosis Type 1 Associated Plexiform Neurofibroma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2018.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}